Skip to main content
. 2021 Nov 3;9:764275. doi: 10.3389/fcell.2021.764275

FIGURE 3.

FIGURE 3

Mutation validation in GIST tumors using PCR-based Sanger DNA sequencing. Some representative variations located in KIT. (A) and other genes (B) were validated using PCR-based Sanger DNA sequencing in GIST tumors.